FEMY · Femasys Inc
$2.92
-0.14 (-4.58%)
At close · Jul 28
Going-concern doubt
— flagged May 8, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, substantial doubt exists about the Company's ability to continue as a going concern for at least one year from the issuance of these financial statements.”View the 10-Q filed May 8, 2026
Market Cap
$176.34M
Shares
60.39M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Kathy Lee-Sepsick | CEO | $566,715 |
| Daniel Currie | Chief Operating Officer | $411,465 |
| Gary Thompson | Vice President, Finance & Administration | $106,917 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John Canning | Chief Operating Officer | Appointed | 2026-04-01 |
| Kenneth D. Eichenbaum, M.D., M.S.E. | director | Appointed | 2026-03-20 |
| Joshua Silverman | director | Resigned | 2026-03-20 |